Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | PGR | P06401 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.54 |
| ▸ | SQLE | Q14534 | 6/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10711405 | 1.00 | ALDH1A1 (0.64) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL6229802 | 0.95 | KMT2A (0.70) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL9953423 | 0.95 | KMT2A (0.70) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL28575170 | 0.82 | NR1I2 (0.76) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL25396940 | 0.80 | ALDH1A1 (0.64) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL1618949 | 0.80 | ALDH1A1 (0.64) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL1618947 | 0.80 | ALDH1A1 (0.64) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL27449251 | 0.79 | KMT2A (0.67) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL2896117 | 0.78 | KMT2A (0.73) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL5323634 | 0.78 | ALDH1A1 (0.61) | ALDH1A1KMT2AMEN1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9580399-B2 | Geranyl flavonoid derivative with improved water solubility, a method for preparing the same, and a method for treating cancer using the same | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2017-02-28 | — | — | US | claimed |
| US-20160060239-A1 | GERANYL FLAVONOID DERIVATIVE WITH IMPROVED WATER SOLUBILITY, A METHOD FOR PREPARING THE SAME, AND A METHOD FOR TREATING CANCER USING THE SAME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2016-03-03 | — | — | US | claimed |
| EP-0112727-B1 | PROCESS FOR PRODUCING MYRCENOL | Takasago Perfumery Co., Ltd. (JP) | 1988-04-06 | — | — | EP | claimed |
| US-4520212-A | CATALYTIC DEAMINATING 7-HYDROXY-(GERANYL-OR NERYL-) DIALKYLAMINE 7PALLADIUM-PHOSPHINE COMPLEX CATALYST | TAKASAGO PERFUMERY CO., LTD. (JP) | 1985-05-28 | — | — | US | claimed |
| EP-0112727-A2 | Process for producing myrcenol | Takasago Perfumery Co., Ltd. (JP) | 1984-07-04 | — | — | EP | claimed |
| US-4421613-A | TERPENE ALCOHOLS | BUSH BOAKE ALLEN (GB) | 1983-12-20 | — | — | US | claimed |
| JP-59118728-A | — | — | None | — | — | JP | disclosed |
| JP-54119439-A | — | — | None | — | — | JP | disclosed |
| WO-2021105075-A1 | DIBENZOPYRAN AMPK ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS AND USES THEREOF | Société des Produits Nestlé S.A. (CH) | 2021-06-03 | — | — | WO | disclosed |
| US-9580399-B2 | Geranyl flavonoid derivative with improved water solubility, a method for preparing the same, and a method for treating cancer using the same | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2017-02-28 | — | — | US | disclosed |
| US-20160060239-A1 | GERANYL FLAVONOID DERIVATIVE WITH IMPROVED WATER SOLUBILITY, A METHOD FOR PREPARING THE SAME, AND A METHOD FOR TREATING CANCER USING THE SAME | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2016-03-03 | — | — | US | disclosed |
| EP-0112727-B1 | PROCESS FOR PRODUCING MYRCENOL | Takasago Perfumery Co., Ltd. (JP) | 1988-04-06 | — | — | EP | disclosed |
| US-4520212-A | CATALYTIC DEAMINATING 7-HYDROXY-(GERANYL-OR NERYL-) DIALKYLAMINE 7PALLADIUM-PHOSPHINE COMPLEX CATALYST | TAKASAGO PERFUMERY CO., LTD. (JP) | 1985-05-28 | — | — | US | disclosed |
| JP-S59118728-A | PREPARATION OF MYRCENOL | TAKASAGO CORP | 1984-07-09 | — | — | JP | disclosed |
| EP-0112727-A2 | Process for producing myrcenol | Takasago Perfumery Co., Ltd. (JP) | 1984-07-04 | — | — | EP | disclosed |
| JP-S54119439-A | NOVEL SUBSTITUTED CYCLOHEXENE DERIVATIVE AND ITS PREPARATION | KURARAY CO LTD | 1979-09-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160060239-A1 | GERANYL FLAVONOID DERIVATIVE WITH IMPROVED WATER SOLUBILITY, A METHOD FOR PREPARING THE SAME, AND A METHOD FOR TREATING CANCER USING THE SAME | STAT3, JAK2, ILF3 | ALDH1A1 3053/4885KMT2A 2990/4885MEN1 3911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.